1. Home
  2. BCAB vs KVHI Comparison

BCAB vs KVHI Comparison

Compare BCAB & KVHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BCAB
  • KVHI
  • Stock Information
  • Founded
  • BCAB 2007
  • KVHI 1978
  • Country
  • BCAB United States
  • KVHI United States
  • Employees
  • BCAB N/A
  • KVHI N/A
  • Industry
  • BCAB Medicinal Chemicals and Botanical Products
  • KVHI Radio And Television Broadcasting And Communications Equipment
  • Sector
  • BCAB Health Care
  • KVHI Technology
  • Exchange
  • BCAB Nasdaq
  • KVHI Nasdaq
  • Market Cap
  • BCAB 101.0M
  • KVHI 102.8M
  • IPO Year
  • BCAB 2020
  • KVHI 1996
  • Fundamental
  • Price
  • BCAB $1.57
  • KVHI $5.25
  • Analyst Decision
  • BCAB Buy
  • KVHI
  • Analyst Count
  • BCAB 2
  • KVHI 0
  • Target Price
  • BCAB $5.00
  • KVHI N/A
  • AVG Volume (30 Days)
  • BCAB 1.2M
  • KVHI 47.9K
  • Earning Date
  • BCAB 11-07-2024
  • KVHI 11-07-2024
  • Dividend Yield
  • BCAB N/A
  • KVHI N/A
  • EPS Growth
  • BCAB N/A
  • KVHI N/A
  • EPS
  • BCAB N/A
  • KVHI N/A
  • Revenue
  • BCAB $11,000,000.00
  • KVHI $118,366,000.00
  • Revenue This Year
  • BCAB N/A
  • KVHI N/A
  • Revenue Next Year
  • BCAB N/A
  • KVHI N/A
  • P/E Ratio
  • BCAB N/A
  • KVHI N/A
  • Revenue Growth
  • BCAB N/A
  • KVHI N/A
  • 52 Week Low
  • BCAB $1.14
  • KVHI $4.17
  • 52 Week High
  • BCAB $4.02
  • KVHI $5.49
  • Technical
  • Relative Strength Index (RSI)
  • BCAB 40.91
  • KVHI 66.06
  • Support Level
  • BCAB $1.33
  • KVHI $4.35
  • Resistance Level
  • BCAB $2.53
  • KVHI $5.23
  • Average True Range (ATR)
  • BCAB 0.26
  • KVHI 0.25
  • MACD
  • BCAB -0.07
  • KVHI 0.07
  • Stochastic Oscillator
  • BCAB 20.08
  • KVHI 84.91

About BCAB BioAtla Inc.

BioAtla Inc is a clinical-stage biopharmaceutical company. The company is engaged in the development of a novel class of specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its pipeline products comprise mecbotamab vedotin (BA3011), ozuriftamab vedotin (BA3021), and evalstotug (BA3071), and its Phase 1 clinical trial of BA3182 (CAB-EpCAM x CAB-CD3) and Bispecific antibody programs.

About KVHI KVH Industries Inc.

KVH Industries Inc provide integrated, end-to-end services, software, and hardware that support its customers' need for access to the Internet, VoIP, operations content, and entertainment services. The company also provides commercially licensed entertainment, including news, sports, music, and movies, to commercial and leisure customers in the maritime, hotel, and retail markets. The Company operates in a number of geographic areas, including internationally. The Revenues are generated from international locations, mainly consisting of Singapore, Canada, European Union countries and other European countries, countries in Africa, Asia/Pacific and the Middle East, and India.

Share on Social Networks: